β-Thalassemia: Expert Insights on New Therapies for an Old Disease

In this CME-certified, on-demand Webcast of a CCO symposium at ASH 2019, a panel of experts discusses current management of β-thalassemia, the evolving role of biologic therapies changing the course of this disease, and the promise of gene therapy for a cure, including guidance on a series of patient cases and panel question and answer session.
Maria Domenica Cappellini, MD
Janet L. Kwiatkowski, MD, MSCE
Sujit Sheth, MD
Released: January 15, 2020 Expiration: No longer available for credit

Related Content

Clinical commentary from European hematology experts on key clinical trials presented at the virtual EHA 2021 meeting, from Clinical Care Options (CCO)

Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, FMedSci María-Victoria Mateos, MD, PhD Lydia Scarfò, MD Ali T. Taher, MD, PhD, FRCP Released: July 28, 2021

Downloadable slideset with highlights from key blood cancers and nonmalignant blood disorders as presented at EHA Virtual Congress 2021, from Clinical Care Options (CCO)

Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, FMedSci María-Victoria Mateos, MD, PhD Lydia Scarfò, MD Ali T. Taher, MD, PhD, FRCP Released: July 16, 2021

Dr. Corey S. Cutler shares his views on current and future graft-vs-host disease (GVHD) therapies in this commentary from Clinical Care Options (CCO)

Corey S. Cutler, MD, MPH, FRCPC Released: April 27, 2021

Interactive online tool providing expert management recommendations for β-thalassemia from Clinical Care Options (CCO)

Jeanne Boudreaux, MD person default Stephanie A. Fritch Lilla, MD Janet L. Kwiatkowski, MD, MSCE Sujit Sheth, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: April 22, 2021 Expired: April 21, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Celgene Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue